Robert Gross

10.7k total citations · 1 hit paper
265 papers, 7.9k citations indexed

About

Robert Gross is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Robert Gross has authored 265 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Infectious Diseases, 58 papers in Virology and 52 papers in Epidemiology. Recurrent topics in Robert Gross's work include HIV/AIDS Research and Interventions (106 papers), HIV/AIDS drug development and treatment (59 papers) and HIV Research and Treatment (58 papers). Robert Gross is often cited by papers focused on HIV/AIDS Research and Interventions (106 papers), HIV/AIDS drug development and treatment (59 papers) and HIV Research and Treatment (58 papers). Robert Gross collaborates with scholars based in United States, Botswana and United Kingdom. Robert Gross's co-authors include Jean B. Nachega, Robert Grossberg, David R. Bangsberg, Ian Frank, Michael J. Mugavero, Gregory P. Bisson, George A. O’Toole, Russell D. Monds, Peter D. Newell and Robert S. Hogg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Nucleic Acids Research.

In The Last Decade

Robert Gross

255 papers receiving 7.7k citations

Hit Papers

Guidelines for Improving Entry Into and Retention in Care... 2012 2026 2016 2021 2012 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Gross United States 47 4.2k 2.0k 1.8k 1.1k 1.0k 265 7.9k
Jan M. Prins Netherlands 57 4.4k 1.0× 5.0k 2.4× 2.6k 1.4× 629 0.6× 1.0k 1.0× 402 11.6k
Peter L. Anderson United States 50 7.0k 1.7× 3.5k 1.7× 3.0k 1.7× 417 0.4× 1.1k 1.1× 264 8.4k
Susan Swindells United States 42 5.8k 1.4× 2.3k 1.2× 3.6k 2.0× 501 0.4× 821 0.8× 161 8.6k
Monica Gandhi United States 50 5.4k 1.3× 2.7k 1.3× 2.4k 1.3× 231 0.2× 1.4k 1.3× 305 7.9k
Gregory K. Robbins United States 47 4.2k 1.0× 3.0k 1.5× 4.3k 2.4× 787 0.7× 366 0.4× 143 9.9k
Marek Smieja Canada 45 3.3k 0.8× 3.4k 1.6× 331 0.2× 1.2k 1.1× 694 0.7× 203 8.5k
D. William Cameron Canada 48 4.1k 1.0× 2.9k 1.4× 2.1k 1.2× 945 0.8× 1.1k 1.1× 294 9.7k
Ellie E. Schoenbaum United States 42 5.8k 1.4× 4.1k 2.0× 2.2k 1.2× 212 0.2× 1.6k 1.5× 136 9.1k
Neil M.H. Graham United States 62 3.3k 0.8× 2.6k 1.3× 2.1k 1.1× 701 0.6× 437 0.4× 240 16.4k
Lisa P. Jacobson United States 65 6.2k 1.5× 4.0k 2.0× 5.2k 2.9× 1.3k 1.2× 873 0.8× 300 14.7k

Countries citing papers authored by Robert Gross

Since Specialization
Citations

This map shows the geographic impact of Robert Gross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Gross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Gross more than expected).

Fields of papers citing papers by Robert Gross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Gross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Gross. The network helps show where Robert Gross may publish in the future.

Co-authorship network of co-authors of Robert Gross

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Gross. A scholar is included among the top collaborators of Robert Gross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Gross. Robert Gross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fiks, Alexander G., Dean Karavite, Rinad S. Beidas, et al.. (2023). Provider perspectives on clinical decision support to improve HIV prevention in pediatric primary care: a multiple methods study. SHILAP Revista de lepidopterología. 4(1). 18–18. 5 indexed citations
2.
O’Brien, Thomas C., Judith Feinberg, Robert Gross, & Dolores Albarracín. (2022). Supportive environments during the substance use disorder epidemic in the rural United States: Provider support for interventions and expectations of interactions with providers. Social Science & Medicine. 294. 114691–114691. 1 indexed citations
3.
Schnoll, Robert A., Steven L. Bernstein, Annette R. Kaufman, et al.. (2021). COVID-19 Challenges Confronted by Smoking Cessation Clinical Trials for People Living With HIV: The Experience of Grantees of the US National Cancer Institute. Nicotine & Tobacco Research. 23(9). 1629–1632. 5 indexed citations
4.
Roy, Jason, Michael Z. Levy, Carole L. Wallis, et al.. (2021). Participants Switching to Second-Line Antiretroviral Therapy with Susceptible Virus Display Inferior Adherence and Worse Outcomes: An Observational Analysis. AIDS Patient Care and STDs. 35(12). 467–473. 2 indexed citations
5.
Weissenbacher, Davy, Suyu Ge, Ari Z Klein, et al.. (2021). Active neural networks to detect mentions of changes to medication treatment in social media. Journal of the American Medical Informatics Association. 28(12). 2551–2561. 8 indexed citations
6.
Xu, Zhiheng, Kun Yin, Xiong Ding, et al.. (2021). An integrated E-Tube cap for sample preparation, isothermal amplification and label-free electrochemical detection of DNA. Biosensors and Bioelectronics. 186. 113306–113306. 17 indexed citations
7.
Wileyto, E. Paul, Robert A. Schnoll, David Metzger, et al.. (2020). No differences in delay discounting between smokers with and without HIV. Psychopharmacology. 238(2). 529–537. 2 indexed citations
8.
Schnoll, Robert A., Katrina J. Serrano, Frank T. Leone, et al.. (2020). The effect of varenicline on mood and cognition in smokers with HIV. Psychopharmacology. 237(4). 1223–1231. 9 indexed citations
9.
Okatch, Harriet, Knashawn H. Morales, Rachel Rogers, et al.. (2020). Trends in HIV Treatment Adherence Before and After HIV Status Disclosure to Adolescents in Botswana. Journal of Adolescent Health. 67(4). 502–508. 4 indexed citations
10.
Ashare, Rebecca L., E. Paul Wileyto, Robert Gross, et al.. (2020). Patterns of lapses and recoveries during a quit attempt using varenicline and behavioral counseling among smokers with and without HIV.. Psychology of Addictive Behaviors. 35(7). 788–796. 6 indexed citations
11.
Brickman, Cristina, Kathleen J. Propert, Jessica S. Merlin, et al.. (2019). Treatment and Outcomes of Oropharyngeal Cancer in People with Human Immunodeficiency Virus. AIDS Research and Human Retroviruses. 35(10). 934–940. 5 indexed citations
12.
Ashare, Rebecca L., Katrina J. Serrano, Frank T. Leone, et al.. (2019). Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV. Drug and Alcohol Dependence. 200. 26–33. 35 indexed citations
13.
Ashare, Rebecca L., et al.. (2019). Improved clinical outcomes among persons with HIV who quit smoking. AIDS Care. 32(10). 1217–1223. 7 indexed citations
14.
Petersen, Maya, Erin LeDell, Joshua Schwab, et al.. (2015). Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring. JAIDS Journal of Acquired Immune Deficiency Syndromes. 69(1). 109–118. 42 indexed citations
15.
Ravimohan, Shruthi, Andrew P. Steenhoff, Ann Tierney, et al.. (2013). Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis. The Journal of Infectious Diseases. 208(11). 1784–1793. 24 indexed citations
16.
Remien, Robert H., Curtis Dolezal, Glenn J. Wagner, et al.. (2013). The Association Between Poor Antiretroviral Adherence and Unsafe Sex: Differences by Gender and Sexual Orientation and Implications for Scale-up of Treatment as Prevention. AIDS and Behavior. 18(8). 1541–1547. 18 indexed citations
17.
Umscheid, Craig A., et al.. (2009). Racial Disparities in Hypertension Control, but Not Treatment Intensification. American Journal of Hypertension. 23(1). 54–61. 26 indexed citations
18.
TenHave, Thomas R., et al.. (2008). Lack of Association between Retrospectively Collected Pharmacy Refill Data and Electronic Drug Monitoring of Antiretroviral Adherence. AIDS and Behavior. 14(4). 748–754. 12 indexed citations
19.
Bisson, Gregory P., Brian L. Strom, Robert Gross, et al.. (2005). Effect of GB virus C viremia on HIV acquisition and HIV set-point. AIDS. 19(16). 1910–1912. 10 indexed citations
20.
Gross, Robert, Harvey M. Friedman, Warren B. Bilker, J. C. Coyne, & Brian L. Strom. (2001). Adherence wanes after first month of HIV therapy. Clinical Pharmacology & Therapeutics. 69(2). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026